Adial Pharmaceuticals(ADIL) - 2025 Q2 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 14, 2025 (Address of principal executive offices and zip code) (804) 487-8196 (Registrant's telephone number including area code) N/A (Former name or former address, if changed since last report) Adial Pharmaceuticals, Inc. (Exact name of registrant as specified in charter) | Delaware | ...